Scientists launch massive biobank to unlock secrets of portal hypertension
NCT ID NCT07419724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a large collection of medical data and biological samples from 1000 people with portal hypertension, a condition that can cause dangerous bleeding in the esophagus or stomach. The goal is to use advanced technologies like genetics and imaging to better understand the disease and improve how doctors predict and manage complications. Participants must have been diagnosed with portal hypertension and have had a CT scan.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PORTAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can extra doses of an old drug reverse liver scarring?
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
- Could a dissolvable sponge replace medical glue for dangerous stomach vein bleeds?
- Unapproved device tested in early trial
- Could a common supplement help liver patients in intensive care?
- New MRI methods could spot liver damage earlier